Bronchospasm in an asthmatic patient following pancuronium.
D000628:Aminophylline / Q000627:therapeutic use; D000731:Androstanes / Q000009:adverse effects*; D001249:Asthma / Q000150:complications*; D001986:Bronchial Spasm / Q000139:chemically induced* / Q000188:drug therapy; D004809:Ephedrine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D010100:Oxygen / Q000627:therapeutic use; D010197:Pancuronium / Q000009:adverse effects; D012121:Respiration, Artificial; D012882:Skin Tests
D000731:Androstanes; D003473:Neuromuscular Nondepolarizing Agents; D000628:Aminophylline; D004809:Ephedrine; D010197:Pancuronium; D010100:Oxygen